Genprex

Developer of therapeutics to treat cancer at molecular level

placeAustin, Texas, United States calendar_todayFounded 2009 groups28 employees language genprex.com

Registered entities

Innovation

8 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 19 times.

YearFilings
20221
20231
20242
20254
20262

Social engagement

Social engagement: 4.5K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

3 investors on record; lead investors include Inception Capital Management; 1 has since exited.

Investor typeCountShare
Private equity133%
Accelerator & incubator133%
Other / undisclosed133%

Recent activity

17 Jun 2026
Event
BIO International Convention 2026
2 Jun 2026
Event
ASCO2026
26 May 2026
Event
2026 ASCO Annual Meeting
Coming soon